United States · FDA National Drug Code directory
Arazlo
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0187-2098_06456968-fe83-2c27-e063-6294a90af3ea
- Product NDC
- 0187-2098
- Form
- LOTION
- Composition / generic term
- tazarotene
- Labeler
- Bausch Health US, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20191219
- Source listing expiry
- 20261231
Source-listed ingredients
- TAZAROTENE — .45 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TUBE in 1 CARTON (0187-2098-10) / 3 g in 1 TUBE (0187-2098-03) · 0187-2098-10
- 1 TUBE in 1 CARTON (0187-2098-45) / 45 g in 1 TUBE · 0187-2098-45
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →